Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/10/2025

Myofascial Pain Syndrome Secondary to Shoulder Dyskinesia: Key Facts and Guidelines

Pathophysiology and Differential Diagnoses

  • The American College of Physicians recommends considering adhesive capsulitis (frozen shoulder) as a differential diagnosis, distinguished by progressive loss of both active and passive range of motion in all planes, particularly external rotation and abduction, with a characteristic capsular pattern; myofascial pain syndrome (MPS) typically maintains passive ROM even when active ROM is limited 1
  • The American Academy of Physical Medicine and Rehabilitation suggests that rotator cuff pathology, including rotator cuff tear and tendinopathy/impingement, should be considered as a differential diagnosis, presenting with weakness in specific planes and positive special tests; imaging confirms diagnosis 1
  • Glenohumeral instability, characterized by a history of subluxation or dislocation, positive apprehension and relocation tests, often in younger patients with trauma history, should also be considered as a differential diagnosis 1

Evidence-Based Physical Therapy Treatment Protocols

  • The American Physical Therapy Association recommends manual physical therapy techniques, including trigger point resolution, muscle lengthening, and fascial restriction release, as the cornerstone of initial treatment for MPS secondary to shoulder dyskinesia 4
  • A scapular stabilization program, including a progressive strengthening program targeting scapular stabilizers and rotator cuff muscles, combined with postural retraining, is a key component of treatment; the program should include exercises such as scapular setting, postural correction, and gentle ROM exercises 2

Pharmacological Management

  • The American College of Rheumatology suggests using NSAIDs, such as diclofenac patches, for symptomatic relief of myofascial pain; topical agents, including lidocaine patches and topical diclofenac, offer localized pain relief without systemic side effects 4
  • Muscle relaxants, such as thiocolchicoside, may be considered for documented muscle spasm; tricyclic antidepressants or SNRIs may be used for persistent pain, particularly when sleep disturbance or central sensitization is present 4

Interventional Procedures

  • The American Academy of Physical Medicine and Rehabilitation recommends considering trigger point injections as part of a comprehensive multimodal program, not standalone therapy, after 3+ months of failed conservative treatment; injections should be limited to 4 sets maximum to assess therapeutic response 3
  • Corticosteroid injections, including intra-articular triamcinolone injections, may be considered for concomitant adhesive capsulitis or glenohumeral joint pathology; subacromial injections may be used when impingement syndrome coexists with MPS 1
  • Botulinum toxin injections, such as onabotulinumtoxinA, may be considered for persistent myofascial pain; these have shown significant benefit in randomized controlled trials 5

REFERENCES

2

Treatment of Myofascial Pain Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Medical Necessity Determination for Myofascial Pain Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Treatment Options for Piriformis Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025